Weekly Carfilzomib Combination Shows MRD Negativity in Multiple Myeloma
Written by
Cancer Network
Published
0
comments
0
min
The safety profile of carfilzomib, lenalidomide, and dexamethasone was tolerable in fit patients with newly diagnosed multiple myeloma.